Katharina M. Busl, MD, MS, FAAN, Guest Editor
Associate Professor, Neurology and Neurosurgery Chief, Division of Neurocritical Care, University of Florida College of Medicine; Medical Director, Neurosciences Intensive Care Unit, University of Florida Health Shands Hospital, Gainesville, Florida

*Relationship Disclosure: Dr Busl serves as a consultant for Guidepoint Global, LLC and Techspert.io Ltd.
**Unlabeled Use of Products/Investigational Use Disclosure: Dr Busl reports no disclosure.

Torrey Boland Birch, MD

Associate Professor, Department of Neurological Sciences; Director, Neurocritical Care Fellowship Program, Rush University Medical Center, Chicago, Illinois

*Relationship Disclosure: Dr Birch serves on an advisory board for Gift of Hope Organ & Tissue Donor Network and has served as a consultant for the legal fi rm Rhoades McKee PC.
**Unlabeled Use of Products/Investigational Use Disclosure: Dr Birch reports no disclosure.

Sherry Hsiang-Yi Chou, MD, MSc, FNCS, FCCM

Associate Professor; Chief, Division of Neurocritical Care, Ken and Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois

*Relationship Disclosure: Dr Chou serves on the board of directors of the Neurocritical Care Society, on an advisory board for CSL Behring, and on the editorial board of Stroke. Dr Chou receives research/grant support from the National Institute of Neurological Diseases and Stroke (R21NS113037) and the National Institutes of Health/National Center for Advancing Translational Sciences (UL1 TR001857).
**Unlabeled Use of Products/Investigational Use Disclosure: Dr Chou reports no disclosure.

Claire J. Creutzfeldt, MD

Associate Professor of Neurology, University of Washington, Seattle, Washington

**Relationship Disclosure: Dr Creutzfeldt serves on the board of directors of the International Neuropalliative Care Society and on the editorial board of Neurologyand receives research/grant support from the National Institute of Neurological Disorders and Stroke (K23 NS099421).
**Unlabeled Use of Products/Investigational Use Disclosure: Dr Creutzfeldt reports no disclosure.

Matthew P. Kirschen, MD, PhD

Assistant Professor, University of Pennsylvania Perelman School of Medicine; Associate Director, Pediatric Neurocritical Care, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania

*Relationship Disclosure: Dr Kirschen has received research/grant support from the Neurocritical Care Society.
**Unlabeled Use of Products/Investigational Use Disclosure: Dr Kirschen reports no disclosure.

Ariane Lewis, MD

Professor, Departments of Neurology and Neurosurgery; Director of Neurocritical Care, NYU Langone Medical Center, New York, New York

*Relationship Disclosure: Dr Lewis serves as a deputy editor for Neurologyand Seminars in Neurology.
**Unlabeled Use of Products/Investigational Use Disclosure: Dr Lewis reports no disclosure.

Eric M. Liotta, MD, MS

Associate Professor of Neurology and Surgery–Organ Transplantation, Northwestern University Feinberg School of Medicine, Chicago, Illinois

*Relationship Disclosure: Dr Liotta serves on the editorial board of Critical Care Explorations and has received personal compensation for a speaking engagement from Penumbra, Inc and research/grant support from the National Institutes of Health (L30 NS098427).
**Unlabeled Use of Products/Investigational Use Disclosure: Dr Liotta reports no disclosure.

Carolina B. Maciel, MD, MSCR

Assistant Professor of Neurology and Neurosurgery, University of Florida, Gainesville, Florida

*Relationship Disclosure: Dr Maciel serves on the editorial boards of Critical Care Explorations, eNeurologicalSci,and Neurocritical Care ON CALL.
**Unlabeled Use of Products/Investigational Use Disclosure: Dr Maciel reports no disclosure.

Christa O’Hana S. Nobleza, MD, MSCI

Associate Professor of Neurology, Division of Neurosciences Critical Care, University of Mississippi, Jackson, Mississippi

*Relationship Disclosure: Dr Nobleza reports no disclosure.
**Unlabeled Use of Products/Investigational Use Disclosure: Dr Nobleza reports no disclosure.

Michael A. Pizzi, DO, PhD

Assistant Professor of Neurology and Neurosurgery, Division of Neurocritical Care, University of Florida, Gainesville, Florida

*Relationship Disclosure: Dr Pizzi reports no disclosure.
**Unlabeled Use of Products/Investigational Use Disclosure: Dr Pizzi reports no disclosure.

Christopher P. Robinson, DO, MS

Assistant Professor of Neurology and Neurosurgery, University of Florida College of Medicine, Gainesville, Florida

*Relationship Disclosure: Dr Robinson has provided legal consulting for Thompson and Evangelo PA. Unlabeled Use of Products/Investigational Use Disclosure: Dr Robinson reports no disclosure.
**Eric S. Rosenthal, MD

Eric S. Rosenthal, MD

Assistant Professor, Harvard Medical School; Director, Neurosciences Intensive Care Unit, Massachusetts General Hospital, Boston, Massachusetts

*Relationship Disclosure: Dr Rosenthal serves on scientific advisory boards for Ceribell, Inc and UCB, Inc and has received personal compensation for speaking engagements from UCB, Inc. Dr Rosenthal receives research/grant support from Moberg Analytics, Inc (DoD W81XWH-18- DMRDP-PTCRA) and the National Institutes of Health/National Institute of Neurological Diseases and Stroke (1R01NS117904, 1R01NS113541, 1K23NS105950, U54NS100064, DoD W81XWH-BAA-15-1).
**Unlabeled Use of Products/Investigational Use Disclosure: Dr Rosenthal discusses the unlabeled/investigational use of IV injection of ketamine, midazolam, and propofol for the treatment of seizures.

Aarti Sarwal, MD, FNCS, FAAN, FCCM, RPNI

Professor, Department of Neurology; Section Chief, Neurocritical Care; Medical Director, Neurocritical Care Unit, Wake Forest School of Medicine, Winston-Salem, North Carolina

*Relationship Disclosure: Dr Sarwal has served as a consultant for Lungpacer Medical Inc; has received personal compensation for speaking engagements for the American Physical Therapy Association, the Neurocritical Care Society, and the Society of Critical Care Medicine; and has received research/ grant support from the Clinical Translational Science Institute (supported by the National Center for Advancing Translational Sciences) and the National Institutes of Health (UL1TR001420).
**Unlabeled Use of Products/Investigational Use Disclosure: Dr Sarwal discusses the unlabeled/investigational use of dexmedetomidine, gabapentinoids, muscle relaxants, and nerve blocks for postoperative headaches; steroids for retraction edema; and intraarterial verapamil, nicardipine, and nimodipine for catheter-induced vasospasm.

Aneesh B. Singhal, MD, FAAN, FANA, FAHA

Associate Professor of Neurology, Harvard Medical School; Vice Chair of Neurology, Director, Comprehensive Stroke Center, Massachusetts General Hospital, Boston, Massachusetts

*Relationship Disclosure: Dr Singhal has served as a consultant for Deck Therapeutics and Omniox; received research/grant support from the National Institutes of Health/National Institute of Neurological Disorders and Stroke (R01NS105875, U10NS086729, U01NS095869) and publishing royalties/honoraria from MedLink, LLC and UpToDate, Inc; and provided expert legal testimony on posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome. Dr Singhal’s wife is an employee of Biogen.
**Unlabeled Use of Products/Investigational Use Disclosure: Dr Singhal discusses the unlabeled/investigational use of glucocorticoids, intraarterial vasodilator therapy, and nimodipine calcium channel blockers for the treatment of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome.